Sign in

    Prahlad Singh

    President and Chief Executive Officer at Revvity Inc
    Board
    Since December 30, 2019
    Age
    60 years
    Education
    Holds a doctoral degree in chemistry from the University of Missouri-Columbia and an MBA from Northeastern University.
    Tenure
    Joined RVTY in May 2014 as President of the Diagnostics business, served as Senior Vice President and Executive Vice President, then as President and COO beginning January 2019 before becoming President and CEO on December 30, 2019.

    Also at Revvity Inc

    AG
    Anita Gonzales
    Vice President and Controller
    DRT
    Daniel R. Tereau
    Senior Vice President, Strategy and Business Development
    JSG
    Joel S. Goldberg
    Senior Vice President, Administration, General Counsel, and Secretary

    About

    Prahlad Singh is the 60-year-old President and Chief Executive Officer of Revvity, having assumed the role on December 30, 2019.

    He began his tenure at Revvity in May 2014 as the President of the Diagnostics business. Over the years, he has advanced through significant leadership roles, including promotions to Senior Vice President in September 2016, Executive Vice President in March 2018, and later to President and Chief Operating Officer in January 2019 before his current appointment.

    Academically, he holds a doctoral degree in chemistry from the University of Missouri-Columbia and an MBA from Northeastern University. Prior to joining Revvity, he built an impressive career by holding senior executive roles in companies such as GE Healthcare, Philips Healthcare, DuPont Pharmaceuticals, and Bristol-Myers Squibb Medical Imaging, contributing to strategic initiatives and operational excellence in the healthcare sector.

    $RVTY Performance Under Prahlad Singh

    Past Roles

    OrganizationRoleDate RangeDetails
    Revvity (RVTY) President and Chief Operating Officer Jan 2019 - Dec 2019Served prior to being elected CEO on Dec 30, 2019
    Revvity (RVTY) Executive Vice President Mar 2018 - Jan 2019Promoted from Senior VP
    Revvity (RVTY) Senior Vice President Sep 2016 - Mar 2018
    Revvity (RVTY) President of the Diagnostics Business May 2014 - Sep 2016Joined RVTY in May 2014 leading the Diagnostics business
    GE Healthcare General Manager, Women’s Health Business 2012 - 2014Oversaw mammography and bone densitometry businesses; held senior executive roles in strategy, business development and M&A
    Philips Healthcare Senior Executive (Strategy, Business Development & M&A) N/A
    DuPont Pharmaceuticals Leadership Roles N/AHeld roles of increasing responsibility
    Bristol-Myers Squibb Medical Imaging Regional Manager (Asia Pacific & Middle East) N/AManaged the Asia Pacific and Middle East region

    External Roles

    OrganizationRoleDate RangeDetails
    Amphenol Corporation Board Member N/APublicly traded
    Analytical, Life Sciences & Diagnostics Association (ALDA) Board Member N/A
    Massachusetts General Hospital Member, President’s Council N/A

    Fixed Compensation

    Data from  FY 2023
    Component NameAmount ($)Payment ScheduleAdditional Details
    Base Salary1,086,539 N/AFixed yearly salary
    401(k) Company Match15,250 N/AIncluded in All Other Compensation
    Executive Health Program2,227 N/AIncluded in All Other Compensation
    Life Insurance Premiums15,000 N/AIncluded in All Other Compensation

    Performance Compensation

    Data from  FY 2023

    Performance Metrics

    MetricWeight (%)ThresholdTargetMaximumActual Result
    Non-COVID Organic Revenue40 7.0% 9.0% 12.0% 2.0% (0% achievement)
    Adjusted EPS40 $4.85 $5.15 $5.55 $4.78 (0% achievement)
    Free Cash Flow Conversion20 70% 80-85% 100% 77% (85% achievement)

    Award Breakdown

    • Target Award Opportunity: $1,485,000 (135% of base salary)
    • Approved Award: $315,563 (21% of the target award)
    • Evaluation Period: Full fiscal year 2023
    • Vesting Schedule: Not applicable – cash incentive
    • Grant Date / Stock Price: Not applicable as it is not an equity-based award